Oncogenic Long Noncoding RNAs in Prostate Cancer, Osteosarcoma, and Metastasis DOI Creative Commons

Aishah Al-Shehri,

Sherin Bakhashab

Biomedicines, Год журнала: 2023, Номер 11(2), С. 633 - 633

Опубликована: Фев. 20, 2023

Prostate cancer (PC) is a common malignancy and one of the leading causes cancer-related death in men worldwide. Osteosarcoma (OS) most bone cancer, representing 20–40% all cases. Cancer metastasis process by which malignant tumor cells detach from primary site via cascade processes migrate to secondary sites through blood circulation or lymphatic system colonize form tumors. PC has specific affinity based on “seed soil” theory; once reach bone, it becomes incurable. Several studies have identified long noncoding RNAs (lncRNAs) as potential targets for therapy diagnostic prognostic biomarkers. The dysregulation various lncRNAs been found types, including PC, OS, metastasis. However, mechanisms underlying lncRNA oncogenic activity progression are extremely complex remain incompletely understood. Therefore, understanding their role mechanism may help better manage treat this malignancy. aim review summarize current knowledge involvement

Язык: Английский

LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions DOI Open Access
Maliheh Entezari, Afshin Taheriazam,

Sima Orouei

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2022, Номер 154, С. 113609 - 113609

Опубликована: Авг. 27, 2022

Epigenetic factors are critical regulators of biological and pathological mechanisms they could interact with different molecular pathways. Targeting epigenetic has been an idea approach in disease therapy, especially cancer. Accumulating evidence highlighted function long non-coding RNAs (lncRNAs) as cancer initiation development focused on their association downstream targets. microRNAs (miRNAs) the most well-known targets lncRNAs present review focuses lncRNA-miRNA axis malignancy therapy resistance tumors. LncRNA-miRNA regulates cell death such apoptosis autophagy cancers. This affects tumor metastasis via regulating EMT MMPs. Besides, determines sensitivity cells to chemotherapy, radiotherapy immunotherapy. Based studies, can be affected by drugs genetic tools this may affect expression level miRNAs targets, leading suppression/progression. LncRNAs have both tumor-promoting tumor-suppressor functions unique complicated implication therapy. also other signaling networks PI3K/Akt, STAT3, Wnt/β-catenin EZH2 among others. Notably, lncRNA/miRNA considered a signature for diagnosis prognosis

Язык: Английский

Процитировано

61

lncRNA-mediated ceRNA network in bladder cancer DOI Creative Commons
Kun Li,

Tongyue Yao,

Ziqiang Wang

и другие.

Non-coding RNA Research, Год журнала: 2022, Номер 8(2), С. 135 - 145

Опубликована: Дек. 14, 2022

Bladder cancer is a common disease associated with high rates of morbidity and mortality. Although immunotherapy approaches such as adoptive T-cell therapy immune checkpoint blockade have been investigated for the treatment bladder cancer, their off-target effects ability to affect only single targets led clinical outcomes that are far from satisfactory. Therefore, it important identify novel can effectively control tumor growth metastasis. It well known long noncoding RNAs (lncRNAs) powerful regulators gene expression. Increasing evidence has shown dysregulated lncRNAs in involved cell proliferation, migration, invasion, apoptosis, epithelial-mesenchymal transition (EMT). In this review, we focus on roles underlying mechanisms lncRNA-mediated competing endogenous RNA (ceRNA) networks regulation progression. addition, discuss potential targeting ceRNA overcome resistance its association clinicopathological features patients. We hope review will stimulate research develop more effective therapeutic treatment.

Язык: Английский

Процитировано

24

LncRNA DANCR counteracts premature ovarian insufficiency by regulating the senescence process of granulosa cells through stabilizing the interaction between p53 and hNRNPC DOI Creative Commons
Di Sun,

Yining Wang,

Ningxia Sun

и другие.

Journal of Ovarian Research, Год журнала: 2023, Номер 16(1)

Опубликована: Фев. 18, 2023

Premature ovarian insufficiency (POI) is one of the common women reproductive endocrine diseases which adversely impacts female fertility, but etiology and pathogenesis still remain elusive. Recently increasing researches focus on roles lncRNA in POI. LncRNA DANCR was involved cell differentiation multiple cancers. It's highly expressed ovary while role POI unknown.Here, we identify a new related DANCR, negatively contributes to granulosa cells aging follicular atresia. proved be decreasingly patients' cells. Additionally, Dancr knockout (Dancr-/-) mice were constructed characterized with phenotypes fertility decline, compared Dancr+/+ mice. Further, vitro experiments indicated that knockdown led series aging-related changes including proliferation inhibition, cycle G1 arrest DNA damage. Mechanism research revealed binds hNRNPC p53, attenuates binding thus enhancing protein level p53 promoting significantly.The newly identified inhibits p53-dependent by regulating hNRNPC-p53 interaction, eventually counteracting This provides insights into potential target for future diagnosis treatment.

Язык: Английский

Процитировано

17

Tumor‐derived exosome ElNF1‐AS1 affects the progression of gastric cancer by promoting M2 polarization of macrophages DOI
Bo Ma, Jun Wang,

Paheredini Yusufu

и другие.

Environmental Toxicology, Год журнала: 2023, Номер 38(9), С. 2228 - 2239

Опубликована: Июнь 13, 2023

Abstract Background This study attempted to investigate the role of exosome ELFN1‐AS1 in gastric cancer (GC). Methods The used various techniques determine level exosomal GC tissue and cells, including quantitative real‐time PCR . Pull‐down assay dual‐luciferase reporter were employed identify interactions between miR‐4644, as well miR‐4644 PKM. Western blot was explore potential regulatory mechanism. Several vitro assays conducted xenograft models impacts on development, metastasis macrophage polarization. Results upregulated with high enrichment GC‐derived exosomes. Exosomal enhances cell abilities stemness GC. targeted regulated which triggered PKM expression. modulated glycolysis via an HIF‐1α dependent manner GC, promoting M2 polarization recruitment. Furthermore, enhanced growth, vivo. Conclusions suggests that could be a promising biomarker for diagnosis treatment

Язык: Английский

Процитировано

16

Molecular and Therapeutic Roles of Non-Coding RNAs in Oral Cancer—A Review DOI Creative Commons
Vidhya Rekha Umapathy, Prabhu Manickam Natarajan,

Bhuminathan Swamikannu

и другие.

Molecules, Год журнала: 2024, Номер 29(10), С. 2402 - 2402

Опубликована: Май 20, 2024

Oral cancer (OC) is among the most common malignancies in world. Despite advances therapy, worst-case scenario for OC remains metastasis, with a 50% survival rate. Therefore, it critical to comprehend pathophysiology of condition and create diagnostic treatment plans OC. The development high-throughput genome sequencing has revealed that over 90% human encodes non-coding transcripts, or transcripts do not code any proteins. This paper describes function these different kinds RNAs (ncRNAs) as well their intriguing therapeutic potential. onset OC, resistance, are linked dysregulated ncRNA expression. These ncRNAs’ potentially significant roles diagnosis prognosis have been suggested by differing expression blood saliva. We outlined every promising feature ncRNAs this study.

Язык: Английский

Процитировано

6

Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications DOI Open Access
Saurabh Dey, Bini Biswas, Angela Manoj Appadan

и другие.

Cancers, Год журнала: 2023, Номер 15(15), С. 3752 - 3752

Опубликована: Июль 25, 2023

Oral cancer (OC) is among the most prevalent cancers in world. Certain geographical areas are disproportionately affected by OC cases due to regional differences dietary habits, tobacco and alcohol consumption. However, conventional therapeutic methods do not yield satisfying treatment outcomes. Thus, there an urgent need understand disease process develop diagnostic strategies for OC. In this review, we discuss role of various types ncRNAs OC, their promising clinical implications as prognostic or markers targets. MicroRNA (miRNA), long ncRNA (lncRNA), circular RNA (circRNA), PIWI-interacting (piRNA), small nucleolar (snoRNA) major whose involvement emerging. Dysregulated expression ncRNAs, particularly miRNAs, lncRNAs, circRNAs, linked with initiation, progression, well therapy resistance via modulation a series cellular pathways through epigenetic, transcriptional, post-transcriptional, translational modifications. Differential expressions miRNAs lncRNAs blood, saliva extracellular vesicles have indicated potential importance. summarized all aspects management

Язык: Английский

Процитировано

10

IGF2BP2 promotes lncRNA DANCR stability mediated glycolysis and affects the progression of FLT3-ITD + acute myeloid leukemia DOI Creative Commons

Shenghao Wu,

Changwei Chi,

Shanshan Weng

и другие.

APOPTOSIS, Год журнала: 2023, Номер 28(7-8), С. 1035 - 1047

Опубликована: Апрель 15, 2023

Abstract Internal tandem duplication (ITD) is the most common type of FLT3 mutation (FLT3-ITD), accounting for about 25% AML patients. The expression DANCR in FLT3-ITD had not been paid attention to, and whether its regulatory relationship with IGF2BP2 can affect progression was unclear. Our study sought to verify biological role as an m6A reading protein AML. To further explore mechanism AML, provide a basis screening biomarkers development targeted drugs. results show that upregulated FLT3-ITD+ patients cells. Si-IGF2BP2 could inhibit proliferation, glycolytic promote apoptosis MV4-11 RNA stability. This discovery will new horizons early therapy

Язык: Английский

Процитировано

9

Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers DOI
Zongpan Ke, Xuechun Hu,

Yixun Liu

и другие.

Critical Reviews in Oncology/Hematology, Год журнала: 2024, Номер 196, С. 104275 - 104275

Опубликована: Фев. 1, 2024

Язык: Английский

Процитировано

3

Novel insights on oral squamous cell carcinoma management using long non-coding RNAs DOI

Subhayan Sur,

Dimple Davray, Soumya Basu

и другие.

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Год журнала: 2024, Номер 32(10), С. 1589 - 1612

Опубликована: Янв. 1, 2024

Oral squamous cell carcinoma (OSCC) is one of the most prevalent forms head and neck carcinomas (HNSCC) with a poor overall survival rate (about 50%), particularly in cases metastasis. RNA-based cancer biomarkers are relatively advanced concept, non-coding RNAs currently have shown promising roles detection treatment various malignancies. This review underlines function long (lncRNAs) OSCC its subsequent clinical implications. LncRNAs, class RNAs, larger than 200 nucleotides resemble mRNA numerous ways. However, unlike mRNA, lncRNA regulates multiple druggable non-druggable signaling molecules through simultaneous interaction DNA, RNA, proteins, or microRNAs depending on concentration localization cells. Upregulation oncogenic lncRNAs down-regulation tumor suppressor evident tissues body fluids such as blood saliva indicating their potential valuable biomarkers. Targeted inhibition candidate over-expression showed therapeutic

Язык: Английский

Процитировано

3

The emerging landscape of small nucleolar RNA host gene 10 in cancer mechanistic insights and clinical relevance DOI
Jingyu Zhu, Zhongyu Jian,

Fangteng Liu

и другие.

Cellular Signalling, Год журнала: 2025, Номер 127, С. 111590 - 111590

Опубликована: Янв. 10, 2025

Язык: Английский

Процитировано

0